InVivo Therapeutics Corpの発行済株式数
InVivo Therapeutics Corpの発行済株式数は何ですか。
InVivo Therapeutics Holdings Corpの発行済株式数は3.105Mです。
発行済株式数の定義は何ですか。
発行済株式数は、投資家によって承認、発行、購入され、保有されている法人または金融資産のすべての株式である。
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
NASDAQのセクタHealth Careにおける発行済株式数の企業と比べるInVivo Therapeutics Corp
InVivo Therapeutics Corpは何をしますか。
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
InVivo Therapeutics Corpと類似の発行済株式数
- Proseed Indiaの発行済株式数は3.091Mです。
- The Peria Karamalai Tea and Produceの発行済株式数は3.096Mです。
- Fusion Goldの発行済株式数は3.100Mです。
- Crown Toursの発行済株式数は3.100Mです。
- B&Aの発行済株式数は3.100Mです。
- Liminal Biosciences Incの発行済株式数は3.104Mです。
- InVivo Therapeutics Corpの発行済株式数は3.105Mです。
- Rajdarshan Industriesの発行済株式数は3.108Mです。
- Siyata Mobileの発行済株式数は3.113Mです。
- Gaumont SAの発行済株式数は3.115Mです。
- TAAL Enterprisesの発行済株式数は3.116Mです。
- Charles & Colvard Ltdの発行済株式数は3.118Mです。
- Taylor Devicesの発行済株式数は3.119Mです。